Drug Type DNA vaccine, Therapeutic vaccine |
Synonyms NECVAXNEO1, Personalised neoantigen-targeting cancer vaccine( NEC Corp), NECVAX NEO1 |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Phase 2 | Germany | 20 Nov 2024 | |
Solid tumor | Phase 2 | Lithuania | 07 Oct 2024 | |
Solid tumor | Phase 2 | Spain | 07 Oct 2024 | |
Melanoma | Phase 1 | Lithuania | 05 May 2022 | |
Mouth Neoplasms | Phase 1 | Lithuania | 05 May 2022 | |
Non-Small Cell Lung Cancer | Phase 1 | Lithuania | 05 May 2022 | |
Renal Cell Carcinoma | Phase 1 | Lithuania | 05 May 2022 | |
Squamous Cell Carcinoma of Head and Neck | Phase 1 | Lithuania | 05 May 2022 |
Phase 1 | 5 | hyyikncccw(hopupiifrk) = mhpgpbbxkw jqskqkkaeg (rdzhjiwgbf ) View more | Positive | 12 Dec 2024 |